| Filed On | Filing |
|---|---|
| 14 Nov 2025 | SCHEDULE 13G/A |
| 15 Aug 2025 | 15-12G |
| 14 Aug 2025 | SCHEDULE 13G/A |
| 14 Aug 2025 | SCHEDULE 13G/A |
| 07 Aug 2025 | EFFECT |
| 07 Aug 2025 | EFFECT |
| 07 Aug 2025 | SCHEDULE 13D/A |
| 07 Aug 2025 |
Form 4: Atlas Venture Fund XII, L.p., 10% owner and 5 others
Returned 5,836,874 shares to the issuer |
| 05 Aug 2025 | S-8 POS |
| 05 Aug 2025 | S-8 POS |
| 05 Aug 2025 | S-8 POS |
| 05 Aug 2025 | S-8 POS |
| 05 Aug 2025 | POS AM |
| 05 Aug 2025 | POS AM |
| 05 Aug 2025 |
Form 4: Thistle Mary, Director
Returned 5,000 shares to the issuer · Disposed of 68,460 Stock Option Award (Right to Buy) (Disposition to Issuer) |
| 05 Aug 2025 |
Form 4: Kaufmann Petra, Chief Medical Officer
Disposed of 474,000 Stock Option Award (Right to Buy) (Disposition to Issuer) |
| 05 Aug 2025 |
Form 4: Budd Haeberlein Samantha L., Director
Returned 17,000 shares to the issuer · Disposed of 62,690 Stock Option Award (Right to Buy) (Disposition to Issuer) |
| 05 Aug 2025 |
Form 4: Ziolkowski Jennifer Lynn, Director
Returned 4,000 shares to the issuer · Disposed of 844,577 Stock Option Award (Right to Buy) (Disposition to Issuer) |
| 05 Aug 2025 |
Form 4: Booth Bruce, Director
Returned 5,841,874 shares to the issuer · Disposed of 144,446 Stock Option Award (Right to Buy) (Disposition to Issuer) |
| 05 Aug 2025 |
Form 4: Vitorovic Stefan, Director
Returned 5,000 shares to the issuer · Disposed of 44,151 Stock Option Award (Right to Buy) (Disposition to Issuer) |
Loading...
